We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 45

Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record


Apotex loses the war in Canada and the battle in England: UK courts rely on Canadian decision to find Apotex acting unlawfully in cCnada has consequences in eErope
  • Gowling Lafleur Henderson LLP
  • Canada, United Kingdom
  • October 13 2011

Servier developed perindopril erbumine (“perindopril”) which is a successful long lasting ACE inhibitor sold under the trade-mark COVERSYL


Eli Lilly Canada Inc. v. Apotex Inc (2010 FCA 240)
  • Gowling Lafleur Henderson LLP
  • Canada
  • October 27 2010

This was an appeal of the decision of Madame Justice Gauthier (in the Federal Court) who had found that although Lilly met its burden to prove that Apotex infringed eight Lilly process patents related to the manufacture of the antibiotic cefaclor for material imported before June 3, 1998, Lilly failed to do so for the cefaclor imported into Canada after June 3, 1998


Apotex v. Pfizer, motion to strike part of a defence pertaining to res judicata, sildenafil citrate, June 11, 2010
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 16 2010

Apotex applied to impeach Pfizer's patent for Viagra and Pfizer defended alleging, in part, res judicata


Apotex v Syntex and Roche, dismissal of appeal concerning section 8 of PMNOC Regulations, naproxen, June 10, 2010
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 16 2010

Apotex had sued Roche for damages pursuant to s. 8 of the PMNOC Regulations


Novopharm v. The Minister of Health, motion for a confidentiality order in a judicial review application of decision of Minister of Health, drug name confidential, May 26, 2010
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 16 2010

The Minister decided that before a NOC could be issued to Novopharm, Novopharm must address a specific patent on the Patent Register


Pfizer v. Novopharm, appeal of decision of prothonotary to deny Novopharm’s motion for confidentiality in PMNOC Regulations case, pregabalin, June 21, 2010
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 16 2010

Novopharm served a NOA on Pfizer which it had unilaterally designated confidential


AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing


Novopharm v. Eli Lilly, appeals of decisions of the Case Management Prothonotary
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

Eli Lilly appealed two interlocutory decisions made by the Case Management Prothonotary


Merck v. Pharmascience, PMNOC Regulations decision
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

The Court, in a lengthy decision, dismissed an application for prohibition in respect of the drug finasteride, wherein allegations of invalidity had been raised, including grounds of double-patenting, novelty and obviousness